Up-regulation of NOTCH4 gene expression in bipolar disorder.

OBJECTIVE Immunopathogenic mechanisms have been implicated in schizophrenia and bipolar disorder, and genome-wide association studies (GWAS) point to the major histocompatibility complex, a region that contains many immune-related genes. One of the strongest candidate risk genes for schizophrenia and bipolar disorder is the NOTCH4 gene within the major histocompatibility complex. The authors investigated the NOTCH4 gene expression in individuals with bipolar disorder and schizophrenia relative to healthy comparison subjects and identified putative expression quantitative trait loci in and around the NOTCH4 gene. METHOD The authors measured and compared NOTCH4 mRNA in whole blood in 690 individuals (479 patients and 211 healthy comparison subjects) and adjusted for a range of confounders. The authors also genotyped 20 single-nucleotide polymorphisms (SNPs) and investigated possible associations between expression quantitative trait loci and NOTCH4 expression. RESULTS The authors found a strong association between NOTCH4 expression and bipolar disorder after adjusting for a range of confounders and multiple testing. In addition, seven SNPs within the NOTCH4 gene region were associated with enhanced NOTCH4 mRNA levels. Three of these expression quantitative trait loci were independent (not in linkage disequilibrium). CONCLUSIONS The results indicate that the association between NOTCH4 DNA markers and bipolar disorder is related to altered function at the mRNA level, supporting the notion that NOTCH4 pathways are involved in the pathophysiology of bipolar disorder.

[1]  Gerome Breen,et al.  Common Genetic Variants and Gene-Expression Changes Associated with Bipolar Disorder Are Over-Represented in Brain Signaling Pathway Genes , 2012, Biological Psychiatry.

[2]  R. Murray,et al.  How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. , 2012, Schizophrenia bulletin.

[3]  J. Allalunis-Turner,et al.  Notch signaling as a therapeutic target for breast cancer treatment? , 2011, Breast Cancer Research.

[4]  Chunyu Liu,et al.  After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. , 2011, The American journal of psychiatry.

[5]  N. Craddock,et al.  Genome-Wide Association Study of Schizophrenia in a Japanese Population , 2011, Biological Psychiatry.

[6]  M. Berk,et al.  eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors , 2010 .

[7]  Y. Funahashi,et al.  Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity , 2011, Vascular cell.

[8]  D. Grozeva,et al.  Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. , 2011, Human molecular genetics.

[9]  B. Charreau,et al.  Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. , 2010, Biochemical pharmacology.

[10]  S. Djurovic,et al.  Osteoprotegerin levels in patients with severe mental disorders. , 2010, Journal of psychiatry & neuroscience : JPN.

[11]  H. Macdonald,et al.  Notch signaling in the immune system. , 2010, Immunity.

[12]  K. Plate,et al.  Differentiation of the brain vasculature: the answer came blowing by the Wnt , 2010, Journal of angiogenesis research.

[13]  T. Kume.  Novel insights into the differential functions of Notch ligands in vascular formation , 2009, Journal of angiogenesis research.

[14]  A. Bollen,et al.  Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease , 2009, Laboratory Investigation.

[15]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[16]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[17]  E. Brietzke,et al.  Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. , 2009, Journal of affective disorders.

[18]  Michael J. Owen,et al.  Genetics of psychosis; insights from views across the genome , 2009, Human Genetics.

[19]  R. McIntyre,et al.  Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. , 2009, The Journal of clinical psychiatry.

[20]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[21]  A. Eisch,et al.  Cell-intrinsic signals that regulate adult neurogenesis in vivo: insights from inducible approaches. , 2009, BMB reports.

[22]  S. Cichon,et al.  Genomewide association studies: history, rationale, and prospects for psychiatric disorders. , 2009, The American journal of psychiatry.

[23]  I. Melle,et al.  Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. , 2009, Bipolar disorders.

[24]  F. Zannad,et al.  C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway. , 2008, Atherosclerosis.

[25]  Francis J McMahon,et al.  Association study of Wnt signaling pathway genes in bipolar disorder. , 2008, Archives of general psychiatry.

[26]  Emmanuel Stip,et al.  Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review , 2008, Biological Psychiatry.

[27]  A. Martinez Arias,et al.  Wnt/Notch signalling and information processing during development , 2008, Development.

[28]  I. Melle,et al.  Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder , 2007, Psychological Medicine.

[29]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[30]  J. Aster,et al.  Delta-Like 4 Induces Notch Signaling in Macrophages: Implications for Inflammation , 2007, Circulation.

[31]  Sam Richman,et al.  An online database for brain disease research , 2006, BMC Genomics.

[32]  K. Jin,et al.  From angiogenesis to neuropathology , 2005, Nature.

[33]  M. Kutryk,et al.  C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function: Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular Disease , 2004, Circulation.

[34]  K. Iwamoto,et al.  Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders , 2004, Molecular Psychiatry.

[35]  W. Pear,et al.  Notch and the immune system. , 2003, Immunity.

[36]  L. Kedes,et al.  Notch Signaling in Vascular Development , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[37]  R. Post,et al.  High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder , 2003, Biological Psychiatry.